Manos Insights
Des idées, des stratégies et des histoires des premiers jours du logiciel vertical. Un examen de plus près de la façon dont la pensée à long terme stimule la performance, le leadership et la croissance.
Nouvelles
12 août 2026
4 min de lecture
Anju Software, a portfolio company of Manos Software Group, has been named to Everest Group's Top 50™ Pharmaceutical Technology Providers 2026 report.
What the report measures
Everest Group's Top 50 is a global ranking of technology providers serving the pharmaceutical value chain: drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. Everest Group draws on proprietary data submitted by providers and publicly available data, including filings and press releases, to score each company across market adoption, innovation and partnerships, client outcomes, and geographic reach.
Where Anju stands out
Anju's strongest result is in Innovation, Investment, and Partners, the category Everest Group weights second only to market scale, and the one that captures AI integration, cloud capability, and strategic partnerships. On this measure, Anju outperforms the majority of the providers on the Top 50 list, including several companies that placed higher overall on the strength of legacy scale rather than innovation investment. It is a signal that Anju's product investment is being recognized on its own terms, not just as a function of size.
Anju is also one of a smaller group of Top 50 providers with technology recognized across two segments of the pharmaceutical value chain at once: clinical development and sales and marketing. Most providers on the list are credited in a single segment. Everest Group identifies these same two areas as the most active in the industry right now: 62% of Top 50 providers serve clinical development and 48% serve sales and marketing, more than any other segment, driven by the shift to decentralized trials and the ongoing realignment of commercial technology stacks. Anju's footprint in both puts it inside the two areas of highest provider concentration and highest buyer demand identified in the report.
Recent product momentum
The Innovation, Investment, and Partners score reflects specific product work recently completed. Anju introduced two products since 2025 that demonstrate it directly.
Luminee is Anju's AI-powered ecosystem for clinical trial startup. It reads protocols and automatically creates study objects aligned with CDASH and SDTM standards, generates validation rules using natural language processing, and produces the test cases and artifacts needed for user acceptance testing. Anju reports the platform cuts build time by up to 90%, turning builds that typically take three months or more into a matter of days. Luminee won the Best of Show Award at SCOPE Europe in 2025.
Anju also added an AI intake layer to its IRMS MAX case management platform. The system captures voice and email inquiries with real-time transcription and populates case fields automatically. It uses library-aware matching to route adverse event and product complaint signals, then stages drafted responses for MedInfo review, a human-in-the-loop step aligned with 21 CFR Part 11 and GDPR.
Both reflect the same pattern behind Everest Group's ranking: AI embedded directly into regulated pharma workflows.
Why this segment matters
Everest Group's analysis points to two forces reshaping pharma technology in 2026: the move to hybrid and decentralized clinical trials, which requires integrated technology stacks to manage remote data collection and risk-based oversight, and sustained investment in commercial tools as pharma buyers reassess their CRM and engagement platforms. Anju's dual coverage means its technology is built for where the industry is actually spending, not just where it has spent historically.
About Anju Software
Anju Software builds life science technology for clinical research, medical affairs, and data science. Its products, including TrialMaster, IRMS MAX, Pubstrat Max, and TA Scan, support drug and device discovery and commercialization for pharmaceutical, biotech, and contract research organizations worldwide. Anju is a portfolio company of Manos Software Group.
About Everest Group
Everest Group is a global research firm covering technology, business process, and engineering markets. Its Top 50 series ranks providers by objective, weighted criteria rather than qualitative capability assessment. The full Top 50 Pharmaceutical Technology Providers 2026 report is available at https://www.everestgrp.com/report/egr-2026-46-pr-8262
